Your browser doesn't support javascript.
loading
Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy.
Cortellini, Alessio; Di Maio, Massimo; Nigro, Olga; Leonetti, Alessandro; Cortinovis, Diego L; Aerts, Joachim Gjv; Guaitoli, Giorgia; Barbieri, Fausto; Giusti, Raffaele; Ferrara, Miriam G; Bria, Emilio; D'Argento, Ettore; Grossi, Francesco; Rijavec, Erika; Guida, Annalisa; Berardi, Rossana; Torniai, Mariangela; Sforza, Vincenzo; Genova, Carlo; Mazzoni, Francesca; Garassino, Marina Chiara; De Toma, Alessandro; Signorelli, Diego; Gelibter, Alain; Siringo, Marco; Marchetti, Paolo; Macerelli, Marianna; Rastelli, Francesca; Chiari, Rita; Rocco, Danilo; Della Gravara, Luigi; Inno, Alessandro; Michele, De Tursi; Grassadonia, Antonino; Di Marino, Pietro; Mansueto, Giovanni; Zoratto, Federica; Filetti, Marco; Santini, Daniele; Citarella, Fabrizio; Russano, Marco; Cantini, Luca; Tuzi, Alessandro; Bordi, Paola; Minuti, Gabriele; Landi, Lorenza; Ricciardi, Serena; Migliorino, Maria R; Passiglia, Francesco; Bironzo, Paolo.
Afiliación
  • Cortellini A; Division of Cancer, Department of Surgery and Cancer, Imperial College London, London, UK alessiocortellini@gmail.com.
  • Di Maio M; Department of Biotechnology and Applied Clinical Science, University of L'Aquila, L'Aquila, Italy.
  • Nigro O; Department of Oncology and Medical Oncology, University of Turin and AO Ordine Mauriziano, Turin, Italy.
  • Leonetti A; Medical Oncology, ASST dei Sette Laghi, Varese, Italy.
  • Cortinovis DL; Medical Oncology, University Hospital of Parma, Parma, Italy.
  • Aerts JG; Medical Oncology, Azienda Ospedaliera San Gerardo, Monza, Italy.
  • Guaitoli G; Department of Pulmonary Disease, Erasmus Medical Center, Rotterdam, Netherlands.
  • Barbieri F; Dipartimento di Oncologia ed Ematologia, AOU Policlinico di Modena, Modena, Italy.
  • Giusti R; Dipartimento di Oncologia ed Ematologia, AOU Policlinico di Modena, Modena, Italy.
  • Ferrara MG; Medical Oncology Unit, Sant'Andrea Hospital of Rome, Roma, Italy.
  • Bria E; Comprehensive Cancer Center, Fondazione Policlinico Universitario "Agostino Gemelli" IRCCS, Roma, Italy.
  • D'Argento E; Department of Translational Medicine and Surgery, Universitá Cattolica del Sacro Cuore, Roma, Italy.
  • Grossi F; Comprehensive Cancer Center, Fondazione Policlinico Universitario "Agostino Gemelli" IRCCS, Roma, Italy.
  • Rijavec E; Department of Translational Medicine and Surgery, Universitá Cattolica del Sacro Cuore, Roma, Italy.
  • Guida A; Comprehensive Cancer Center, Fondazione Policlinico Universitario "Agostino Gemelli" IRCCS, Roma, Italy.
  • Berardi R; Division of Medical Oncology, University of Insubria, Varese, Italy.
  • Torniai M; Medical Oncology, Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Sforza V; Struttura Complessa di Oncologia Medica e Traslazionale, Azienda Ospedaliera Santa Maria di Terni, Terni, Italy.
  • Genova C; Oncology Clinic, Università Politecnica delle Marche, Ospedali Riuniti di Ancona, Ancona, Italy.
  • Mazzoni F; Oncology Clinic, Università Politecnica delle Marche, Ospedali Riuniti di Ancona, Ancona, Italy.
  • Garassino MC; Thoracic Medical Oncology, National Cancer Institute IRCCS Pascale Foundation, Napoli, Italy.
  • De Toma A; Lung Cancer Unit, IRCCS Ospedal Policlinico San Martino, Genova, Italy.
  • Signorelli D; Department of Medical Oncology, Careggi University Hospital, Firenze, Toscana, Italy.
  • Gelibter A; Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
  • Siringo M; Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
  • Marchetti P; Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
  • Macerelli M; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy.
  • Rastelli F; Medical Oncology Unit B, Policlinico Umberto I, Sapienza University of Rome, Roma, Italy.
  • Chiari R; Medical Oncology Unit B, Policlinico Umberto I, Sapienza University of Rome, Roma, Italy.
  • Rocco D; Department of Clinical and Molecular Medicine, Sapienza University of Rome, Roma, Italy.
  • Della Gravara L; Medical Oncology, University Hospital Santa Maria della Misericordia, Udine, Italy.
  • Inno A; Medical Department, ASUR Area Vasta 4, Fermo, Italy.
  • Michele T; Medical Oncology, Ospedali riuniti Padova Sud "Madre Teresa Di Calcutta", Monselice, Padova, Italy.
  • Grassadonia A; Pneumo-Oncology Unit, Ospedali dei Colli Monaldi Cotugno CTO, Napoli, Italy.
  • Di Marino P; Pneumo-Oncology Unit, Ospedali dei Colli Monaldi Cotugno CTO, Napoli, Italy.
  • Mansueto G; Oncology Unit, IRCCS Ospedale Sacro Cuore Don Calabria, Negrar, Italy.
  • Zoratto F; Dipartimento di Terapie Innovative in Medicina ed Odontoiatria, Universitá G. D'Annunzio, Chieti-Pescara, Italy.
  • Filetti M; Dipartimento di Terapie Innovative in Medicina ed Odontoiatria, Universitá G. D'Annunzio, Chieti-Pescara, Italy.
  • Santini D; Clinical Oncology Unit, SS Annunziata Hospital, Chieti, Italy.
  • Citarella F; Medical Oncology, Azienda Sanitaria Locale Frosinone, Frosinone, Italy.
  • Russano M; Medical Oncology, Ospedale Santa Maria Goretti, Latina, Italy.
  • Cantini L; Medical Oncology Unit, Sant'Andrea Hospital of Rome, Roma, Italy.
  • Tuzi A; Medical Oncology, Campus Bio-Medico University, Roma, Italy.
  • Bordi P; Medical Oncology, Campus Bio-Medico University, Roma, Italy.
  • Minuti G; Medical Oncology, Campus Bio-Medico University, Roma, Italy.
  • Landi L; Department of Pulmonary Disease, Erasmus Medical Center, Rotterdam, Netherlands.
  • Ricciardi S; Oncology Clinic, Università Politecnica delle Marche, Ospedali Riuniti di Ancona, Ancona, Italy.
  • Migliorino MR; Medical Oncology, ASST dei Sette Laghi, Varese, Italy.
  • Passiglia F; Medical Oncology, University Hospital of Parma, Parma, Italy.
  • Bironzo P; Department of Oncology and Hematology, AUSL della Romagna, Ravenna, Italy.
J Immunother Cancer ; 9(4)2021 04.
Article en En | MEDLINE | ID: mdl-33827906
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma de Pulmón de Células no Pequeñas / Anticuerpos Monoclonales Humanizados / Inhibidores de Puntos de Control Inmunológico / Neoplasias Pulmonares / Antibacterianos Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: J Immunother Cancer Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma de Pulmón de Células no Pequeñas / Anticuerpos Monoclonales Humanizados / Inhibidores de Puntos de Control Inmunológico / Neoplasias Pulmonares / Antibacterianos Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: J Immunother Cancer Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido